Change search
ReferencesLink to record
Permanent link

Direct link
LRIG1 restricts growth factor signaling by enhancing receptor ubiquitylation and degradation
Show others and affiliations
2004 (English)In: EMBO Journal, ISSN 0261-4189, Vol. 23, no 16, 3270-3281 p.Article in journal (Refereed) Published
Place, publisher, year, edition, pages
2004. Vol. 23, no 16, 3270-3281 p.
Keyword [en]
Cancer, growth factor, signal transduction, tyrosine kinase, ubiquitin ligase
URN: urn:nbn:se:umu:diva-15328DOI: 10.1038/sj.emboj.7600342PubMedID: 15282549OAI: diva2:155000
Available from: 2007-02-23 Created: 2007-02-23 Last updated: 2009-10-26Bibliographically approved
In thesis
1. The LRIG-family: identification of novel regulators of ErbB signaling with clinical implications in astrocytoma
Open this publication in new window or tab >>The LRIG-family: identification of novel regulators of ErbB signaling with clinical implications in astrocytoma
2006 (English)Doctoral thesis, comprehensive summary (Other academic)
Abstract [en]

Astrocytic tumors are the most common malignancies of the central nervous system, accounting for more than 60% of all primary brain tumors. The prognosis for high grade astrocytoma patients is dismal and there is no curative treatment, today. A molecular hallmark of astrocytic tumors is dysregulated receptor tyrosine kinase signaling, especially of the epidermal growth factor receptor (EGFR, ErbB1). The aim of the present thesis was to identify endogenous human proteins that downregulate the function of the ErbB1 receptor. We identified a human gene family, the leucine-rich repeats and immunoglobulin-like domains family (LRIG), consisting of LRIG1, LRIG2 and LRIG3, which might fulfill this criterion.

Two candidates were identified, LRIG1 and LRIG2, which genes were localized to regions frequently deleted in human cancers, chromosome bands 3p14 and 1p13, respectively. LRIG1 and LRIG2 mRNA were expressed in all tissues analyzed, with high expression in brain and other organs. The LRIG mRNA were predicted to encode integral membrane proteins. Antibodies against LRIG1 and LRIG2 were developed and the protein expression was analyzed. LRIG1 was found to have an apparent molecular weight of 143 kDa and was expressed in most tissues with high expression in glandular tissues of the breast and prostate, and the peptic cells of the stomach. LRIG2 was slightly smaller and had an apparent molecular weight of 132 kDa. The LRIG proteins were localized to the cell surface and to perinuclear structures, where LRIG1 co-localized with the trans-Golgi network and early endosomes.

LRIG1 was found to restrict growth factor signaling by enhancing receptor ubiquitylation and degradation. We showed that LRIG1 interacted with all four members of the ErbB family and induced their downregulation. The interaction with ErbB1 involved both the LRR-domains and the Ig-like domains of LRIG1. LRIG1 enhanced receptor degradation by recruiting the E3 ubiquitin ligase c-Cbl to the LRIG1-ErbB1 complex.

LRIG1, LRIG2, and LRIG3 were expressed in glioma cell lines and tumor tissues. The LRIG expression was analyzed in 404 astrocytic tumor samples. We found that perinuclear LRIG protein expression correlated with increased survival of patients with astrocytic tumors. Especially perinuclear LRIG3 showed strong correlations with patient survival and tumor cell proliferation index.

In summary, this thesis contains the discovery and characterization of human LRIG1 and LRIG2. LRIG1 was found to interact with ErbB receptors and downregulate their function. In a clinical material, expression of LRIG proteins correlated with survival in patients with astrocytic tumors.

Place, publisher, year, edition, pages
Umeå: Umeå universitet, 2006. 41 p.
Umeå University medical dissertations, ISSN 0346-6612 ; 1027
astrocytic tumors, EGFR, ErbB, glioblastoma multiforme, LRIG, negative regulation.
National Category
Cancer and Oncology
urn:nbn:se:umu:diva-783 (URN)91-7264-074-X (ISBN)
Public defence
2006-05-24, 244 Lionssalen, By 7, Norrlands universitetssjukhus, Umeå, 09:00 (English)
Available from: 2006-05-03 Created: 2006-05-03 Last updated: 2012-04-03Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Nilsson, JonasHenriksson, RogerHedman, Håkan
By organisation
In the same journal
EMBO Journal

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 60 hits
ReferencesLink to record
Permanent link

Direct link